DE69425345D1 - Anwendung von Selegilin in Tiermedizin - Google Patents

Anwendung von Selegilin in Tiermedizin

Info

Publication number
DE69425345D1
DE69425345D1 DE69425345T DE69425345T DE69425345D1 DE 69425345 D1 DE69425345 D1 DE 69425345D1 DE 69425345 T DE69425345 T DE 69425345T DE 69425345 T DE69425345 T DE 69425345T DE 69425345 D1 DE69425345 D1 DE 69425345D1
Authority
DE
Germany
Prior art keywords
selegiline
veterinary medicine
cats
dogs
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69425345T
Other languages
English (en)
Other versions
DE69425345T2 (de
Inventor
Marie Sophie Filhol
Thierry Pobel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26230300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69425345(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9305305A external-priority patent/FR2704756B1/fr
Priority claimed from FR9315495A external-priority patent/FR2713930B3/fr
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Application granted granted Critical
Publication of DE69425345D1 publication Critical patent/DE69425345D1/de
Publication of DE69425345T2 publication Critical patent/DE69425345T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69425345T 1993-05-04 1994-05-02 Anwendung von Selegilin in Tiermedizin Expired - Fee Related DE69425345T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9305305A FR2704756B1 (fr) 1993-05-04 1993-05-04 Utilisation de la sélégiline en médecine vétérinaire.
FR9315495A FR2713930B3 (fr) 1993-12-22 1993-12-22 Utilisation de la Sélégiline en médecine vétérinaire.

Publications (2)

Publication Number Publication Date
DE69425345D1 true DE69425345D1 (de) 2000-08-31
DE69425345T2 DE69425345T2 (de) 2001-03-01

Family

ID=26230300

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425345T Expired - Fee Related DE69425345T2 (de) 1993-05-04 1994-05-02 Anwendung von Selegilin in Tiermedizin

Country Status (9)

Country Link
US (1) US5547995B1 (de)
EP (1) EP0623344B1 (de)
AT (1) ATE194911T1 (de)
CA (1) CA2122780C (de)
DE (1) DE69425345T2 (de)
DK (1) DK0623344T3 (de)
ES (1) ES2149850T3 (de)
GR (1) GR3034661T3 (de)
PT (1) PT623344E (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002513383A (ja) 1997-05-21 2002-05-08 スローン−ケタリング・インスティテュート・フォー・キャンサー・リサーチ 患者の脳組織でのアスコルビン酸の濃度を増加させる方法
US6262111B1 (en) 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
JP2005504029A (ja) * 2001-07-20 2005-02-10 ファイザー・プロダクツ・インク 犬の好ましくない行動を改善するためのｎｋ−１受容体アンタゴニストの使用
US20050079205A1 (en) * 2003-09-10 2005-04-14 Miller Cheryl C. Oleamide-containing composition for animal consumption
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
CA2107552C (en) * 1991-04-04 2001-08-28 William G. Tatton Use of deprenyl to maintain, prevent loss, or recover nerve cell function

Also Published As

Publication number Publication date
DE69425345T2 (de) 2001-03-01
CA2122780C (fr) 2004-01-20
US5547995A (en) 1996-08-20
CA2122780A1 (fr) 1994-11-05
EP0623344A1 (de) 1994-11-09
GR3034661T3 (en) 2001-01-31
EP0623344B1 (de) 2000-07-26
ES2149850T3 (es) 2000-11-16
ATE194911T1 (de) 2000-08-15
US5547995B1 (en) 1998-01-27
DK0623344T3 (da) 2000-12-18
PT623344E (pt) 2000-12-29

Similar Documents

Publication Publication Date Title
PT93333A (pt) Processo de preparacao de uma composicao biocida sinergica e de tratamento usando a referida composicao
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69127175D1 (de) Antisens-Oligonukleotide zur Behandlung von Krebs
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ID26956A (id) Pencegahan raf kinase menggunakan simetris dan nonsimetris yang digantikan diphenil urea
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE3882775D1 (de) Zusammensetzung zur behandlung von parodontaler krankheit.
ES2082834T3 (es) Composiciones con liberacion prolongada para tratar enfermedades periodontales.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
BR1100384A (pt) Composto e formulação farmacêutica
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE69425345D1 (de) Anwendung von Selegilin in Tiermedizin
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE68909465D1 (de) Behandlung von pferdeviehbestand.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
BR9007874A (pt) Processo para o tratamento posterior de tenso-ativos anfoteros ou zwitterionicos
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee